Coegin Pharma AB (NGM:COEGIN)

Coegin Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.92	19.68	5.55	3.82	25.66
Cash & Short-Term Investments	7.92	19.68	5.55	3.82	25.66
Cash Growth	-59.74%	254.70%	45.39%	-85.13%	54.12%
Accounts Receivable	0.07	-	-	-	-
Other Receivables	0.51	1.15	0.64	3.13	4.64
Receivables	0.58	1.15	0.64	3.13	4.64
Prepaid Expenses	0.27	0.01	0.02	0.02	0.03
Other Current Assets	1.23	-0	-	-	-
Total Current Assets	10	20.84	6.21	6.97	30.33
Property, Plant & Equipment	0.11	0.15	0.3	0.49	0
Long-Term Investments	0.06	-	-	-	-
Other Intangible Assets	3.18	6.05	8.92	11.79	-
Other Long-Term Assets	-	-	-	10	-
Total Assets	13.34	27.04	15.43	29.25	30.34
Accounts Payable	0.64	0.98	1.79	2	9.73
Accrued Expenses	2.59	0.66	2.66	1.71	0.22
Current Income Taxes Payable	0.02	-	-	0.18	-
Other Current Liabilities	5.35	0.15	4.24	4.34	0.31
Total Current Liabilities	8.6	1.78	8.68	8.23	10.26
Total Liabilities	8.6	1.78	8.68	8.23	10.26
Common Stock	12.44	12.44	4.7	35.33	27.57
Additional Paid-In Capital	136.2	136.2	101.6	94.76	66.38
Retained Earnings	-	-	-	-	-75.07
Comprehensive Income & Other	-143.9	-123.38	-99.54	-109.08	1.2
Shareholders' Equity	4.74	25.26	6.75	21.01	20.07
Total Liabilities & Equity	13.34	27.04	15.43	29.25	30.34
Net Cash (Debt)	7.92	19.68	5.55	3.82	25.66
Net Cash Growth	-59.74%	254.70%	45.39%	-85.13%	54.12%
Net Cash Per Share	0.32	1.04	0.60	0.56	4.32
Filing Date Shares Outstanding	24.88	24.88	9.39	6.94	6.94
Total Common Shares Outstanding	24.88	24.88	9.39	6.94	6.94
Working Capital	1.4	19.06	-2.47	-1.26	20.07
Book Value Per Share	0.19	1.02	0.72	3.03	2.89
Tangible Book Value	1.56	19.21	-2.17	9.22	20.07
Tangible Book Value Per Share	0.06	0.77	-0.23	1.33	2.89
Machinery	-	0.63	0.64	0.68	0.15

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.